White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica

Neuromyelitis optica (NMO) is an inflammatory disease of central nervous system characterized by optic neuritis and longitudinally extensive acute transverse myelitis. NMO patients have cognitive dysfunctions but other clinical symptoms of brain origin are rare. In the present study, we aimed to investigate cognitive functions and brain volume in NMO. The study population consisted of 28 patients with NMO and 28 healthy control subjects matched for age, sex and educational level. We applied a French translation of the Brief Repeatable Battery (BRB-N) to the NMO patients. Using SIENAx for global brain volume (Grey Matter, GM; White Matter, WM; and whole brain) and VBM for focal brain volume (GM and WM), NMO patients and controls were compared. Voxel-level correlations between diminished brain concentration and cognitive performance for each tests were performed. Focal and global brain volume of NMO patients with and without cognitive impairment were also compared. Fifteen NMO patients (54%) had cognitive impairment with memory, executive function, attention and speed of information processing deficits. Global and focal brain atrophy of WM but not Grey Matter (GM) was found in the NMO patients group. The focal WM atrophy included the optic chiasm, pons, cerebellum, the corpus callosum and parts of the frontal, temporal and parietal lobes, including superior longitudinal fascicle. Visual memory, verbal memory, speed of information processing, short-term memory and executive functions were correlated to focal WM volumes. The comparison of patients with, to patients without cognitive impairment showed a clear decrease of global and focal WM, including brainstem, corticospinal tracts, corpus callosum but also superior and inferior longitudinal fascicles. Cognitive impairment in NMO patients is correlated to the decreased of global and focal WM volume of the brain. Further studies are needed to better understand the precise origin of cognitive impairment in NMO patients, particularly in the WM.

[1]  B. Weinshenker,et al.  Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. , 2009, Archives of neurology.

[2]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[3]  B. Weinshenker,et al.  Brain abnormalities in neuromyelitis optica. , 2006, Archives of neurology.

[4]  P. Calabresi,et al.  MRI of the corpus callosum in multiple sclerosis: association with disability , 2010, Multiple sclerosis.

[5]  A. Flanders.  Pathogenesis of Normal-appearing White Matter Damage in Neuromyelitis Optica: Diffusion-Tensor MR Imaging , 2009 .

[6]  J. Parisi,et al.  Absence of cortical demyelination in neuromyelitis optica , 2010, Neurology.

[7]  P. Wesseling,et al.  Neuromyelitis optica with clinical and histopathological involvement of the brain , 2007, Multiple sclerosis.

[8]  D. Zaidel,et al.  The case for a relationship between human memory, hippocampus and corpus callosum. , 1995, Biological research.

[9]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[10]  J Grimaud,et al.  Neuromyelitis optica in France , 2010, Neurology.

[11]  Olaf B. Paulson,et al.  White Matter Microstructure in Superior Longitudinal Fasciculus Associated with Spatial Working Memory Performance in Children , 2011, Journal of Cognitive Neuroscience.

[12]  B. Weinshenker,et al.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. , 2006, Archives of neurology.

[13]  Eduardo E. Benarroch,et al.  The locus ceruleus norepinephrine system , 2009, Neurology.

[14]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.

[15]  D. Prayer,et al.  Diffuse White Matter Damage Is Absent in Neuromyelitis Optica , 2010, American Journal of Neuroradiology.

[16]  N. Abdala,et al.  White matter spectroscopy in neuromyelitis optica , 2008, Journal of Neurology.

[17]  P. Brugières,et al.  Devic disease with brainstem lesions. , 2006, Archives of neurology.

[18]  S. Sara.  The locus coeruleus and noradrenergic modulation of cognition , 2009, Nature Reviews Neuroscience.

[19]  Sang Won Seo,et al.  Reversible Verbal and Visual Memory Deficits after Left Retrosplenial Infarction , 2007, Journal of clinical neurology.

[20]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[21]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[22]  Swati Sharma,et al.  Evaluation of brain atrophy estimation algorithms using simulated ground-truth data , 2010, Medical Image Anal..

[23]  Jochen Kaiser,et al.  Basic operations in working memory: Contributions from functional imaging studies , 2010, Behavioural Brain Research.

[24]  Y. Itoyama,et al.  Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. , 2007, Brain : a journal of neurology.

[25]  Antonio Federico,et al.  Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. , 2002, Archives of neurology.

[26]  M Filippi,et al.  Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica , 2004, Neurology.

[27]  Tianzi Jiang,et al.  Pathogenesis of normal-appearing white matter damage in neuromyelitis optica: diffusion-tensor MR imaging. , 2008, Radiology.

[28]  P. Vermersch,et al.  NMO-IgG and Devic's neuromyelitis optica: a French experience , 2008, Multiple sclerosis.

[29]  Chaozhe Zhu,et al.  Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica. , 2006, AJNR. American journal of neuroradiology.

[30]  Frédéric Blanc,et al.  Cognitive functions in neuromyelitis optica. , 2008, Archives of neurology.

[31]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[32]  Daniel J. Acheson,et al.  Areas of left perisylvian cortex mediate auditory–verbal short-term memory , 2011, Neuropsychologia.

[33]  E. Tulving.  Episodic memory: from mind to brain. , 2002, Annual review of psychology.

[34]  J. Parisi,et al.  Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. , 2007, Brain : a journal of neurology.

[35]  K. Dujardin,et al.  [BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis]. , 2004, Revue neurologique (Paris).

[36]  J. D. Sèze,et al.  La BCcogSEP : une batterie courte d'évaluation des fonctions cognitives destinées aux patients souffrant de sclérose en plaques , 2004 .

[37]  M. Moscovitch,et al.  The parietal cortex and episodic memory: an attentional account , 2008, Nature Reviews Neuroscience.

[38]  Y. Itoyama,et al.  An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion , 2005 .

[39]  H. Eichenbaum,et al.  Towards a functional organization of the medial temporal lobe memory system: Role of the parahippocampal and medial entorhinal cortical areas , 2008, Hippocampus.

[40]  S. Kremer,et al.  Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  Qiyong Gong,et al.  Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse , 2011, Brain and Cognition.